Sou Hu Cai Jing·2025-11-03 11:30Core Insights - The stock of Chunli Medical (688236) closed at 28.76 yuan on November 3, 2025, down 0.42% with a trading volume of 52,900 lots and a turnover of 152 million yuan [1] Group 1: Financial Performance - Chunli Medical reported a total revenue of 755.6 million yuan for the first three quarters of 2025, representing a year-on-year increase of 48.75% [2] - The net profit attributable to shareholders for the same period was 192 million yuan, up 213.21% year-on-year [2] - The company's third-quarter revenue was 268 million yuan, showing a significant year-on-year increase of 109.51% [2] - The gross profit margin for Chunli Medical stands at 67.27%, which is higher than the industry average of 51.22% [2] Group 2: Market Position and Valuation - Chunli Medical has a total market capitalization of 11.031 billion yuan, ranking 34th in the medical device industry [2] - The company's price-to-earnings (P/E) ratio is 43.2, which is lower than the industry average of 63.42, ranking 47th [2] - The return on equity (ROE) for Chunli Medical is 6.6%, significantly higher than the industry average of 0.15% [2] Group 3: Investment Sentiment - In the last 90 days, 8 institutions have rated Chunli Medical, with 7 buy ratings and 1 hold rating [3] - The average target price set by institutions for Chunli Medical is 31.02 yuan [3]